Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: CERAMEDIX HOLDING, LLC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2020-09-28 to 2023-09-27
Current total value of award: $4496897.16
Description: ANTICERAMIDE SCFV AS PROPHYLAXIS OF THE RADIATION GI SYNDROM FOR THE JOINT WARFIGHTER MEDICAL RESEARCH PROGRAM